The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: A pilot study

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 4281-4285

  Nisman, Benjamin ^a   Yutkin, Vladimir ^a   Peretz, Tamar ^a   Shapiro, Amos ^a   Barak, Vivian ^a   Pode, Dov ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Abdominal ultrasound; Bladder cancer; Surveillance; Urine CYFRA 21 1; Urine cytology

Indexed keywords

BCG VACCINE; CYTOKERATIN 19 FRAGMENT;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; BLADDER MUSCLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PILOT STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; ULTRASOUND; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-19; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 71949119890     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pfister C, Chautard D, Devonec M, Perrin P, Chopin D, Rischmann P, Bouchot O, Beurton D, Coulange C and Rambeaud JJ: Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol 169: 921-924, 2003. (Pubitemid 36188123)
2. Herr HW: Uncertainty, stage and outcome of invasive bladder cancer. J Urol 152: 401-402, 1994. (Pubitemid 24221229)
3. Lamm D, Colombel M, Persad R, Soloway M, Bohle A, Palou J, Witjes JA, Akaza H, Buckley R and Brausi M: Clinical Practice Recommendations for the Management of Non-Muscle Invasive Bladder Cancer. European Urology Supplements 7: 651-666, 2008.
4. NCCN Clinical Practice Guidelines in OncologyTM: Bladder Cancer Including Upper Tract Tumors and Urothelial Carcinoma of the Prostate. National Comprehensive Cancer Network, 2009
5. Koss LG: Tumors of the urinary tract and prostate in urinary sediment. In: Diagnostic cytology and its histopathologic bases. 4th ed. Koss LG (ed.). Philadelphia: Lippincott Co., pp. 951-963, 1992.
6. Bodenmuller H: The biochemistry of CYFRA 21-1 and other cytokeratin tests. Scand J Clin Lab Invest Suppl 221: 60-66, 1995.
7. van Rhijn BW, van der Poel HG and van der Kwast TH: Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47: 736-748, 2005. (Pubitemid 40745338)
8. Fernandez-Gomez J, Rodriguez-Martinez JJ, Barmadah SE, Garcia Rodriguez J, Allende DM, Jalon A, Gonzalez R and Alvarez-Mugica M: Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer. Eur Urol 51: 1267-1274, 2007. (Pubitemid 46436313)
9. Pavlica P, Gaudiano C and Barozzi L: Sonography of the bladder. World J Urol 22: 328-334, 2004.
10. Dershaw DD and Scher HI: Serial transabdominal sonography of bladder cancer. AJR Am J Roentgenol 150: 1055-1059, 1988.
11. Nisman B, Barak V, Shapiro A, Golijanin D, Peretz T and Pode D: Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma. Cancer 94: 2914-2922, 2002. (Pubitemid 34547690)
12. Epstein JI, Amin MB, Reuter VR and Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22: 1435-1448, 1998.
13. Abramson J: WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1: 6, 2004.
14. Pariente JL, Bordenave L, Michel P, Latapie MJ, Ducassou D and Le Guillou M: Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma. J Urol 158: 338-341, 1997. (Pubitemid 27327662)
15. Sanchez-Carbayo M, Herrero E, Megias J, Mira A and Soria F: Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer. J Urol 162: 1951-1956, 1999.
16. Sanchez-Carbayo M, Urrutia M, Gonzalez de Buitrago JM and Navajo JA: Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma. Cancer 92: 2820-2828, 2001. (Pubitemid 33091918)
17. Brun B, Gammelgaard J and Christoffersen J: Transabdominal dynamic ultrasonography in detection of bladder tumors. J Urol 132: 19-20, 1984. (Pubitemid 14087460)
18. Lopes RI, Nogueira L, Albertotti CJ, Takahashi DY and Lopes RN: Comparison of virtual cystoscopy and transabdominal ultrasonography with conventional cystoscopy for bladder tumor detection. J Endourol 22: 1725-1729, 2008.
19. Cariou G, Maaraoui N and Cortesse A: Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?. Prog Urol 7: 51-55, 1997 (in French). (Pubitemid 127525180)
20. Pode D, Golijanin D, Sherman Y, Lebensart P and Shapiro A: Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors. J Urol 159: 389-392, 1998. (Pubitemid 28049239)
21. Tsihlias J and Grossman HB: The utility of fibrin/fibrinogen degradation products in superficial bladder cancer. Urol Clin North Am 27: 39-46, 2000. (Pubitemid 30085996)
22. Gibanel R, Ribal MJ, Filella X, Ballesta AM, Molina R, Alcaraz A and Alcover JB: BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder. Anticancer Res 22: 1157-1160, 2002. (Pubitemid 34836166)
23. Mian C, Lodde M, Comploj E, Palermo S, Mian M, Maier K and Pycha A: The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder. Anticancer Res 25: 3641-3644, 2005. (Pubitemid 41105255)
24. Vriesema JL, Poucki MH, Kiemeney LA and Witjes JA: Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis. Urology 56: 793-797, 2000.
25. Soloway MS, Bruck DS and Kim SS: Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol 170: 438-441, 2003.